ArticleFrontiers in pharmacology2014

The effects of angiotensinogen gene polymorphisms on cardiovascular disease outcomes during antihypertensive treatment in the GenHAT study.

Anh N Do et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.